GATA3 rs3824662 gene polymorphism as possible risk factor for systemic lupus erythematosus

Area of Science:

• Genetics
• Immunology
• Rheumatology

Background:

• Limited research exists on the association between GATA3 rs3824662 polymorphism and systemic lupus erythematosus (SLE).
• Investigating genetic factors like GATA3 polymorphism is crucial for understanding SLE pathogenesis.

Purpose of the Study:

• To determine if the GATA3 rs3824662 polymorphism acts as a susceptibility risk factor for adult SLE (aSLE) and pediatric SLE (pSLE).
• To assess the role of this polymorphism in the development of lupus nephritis (LN) specifically within pediatric SLE patients.

Main Methods:

• Genotyping of the GATA3 rs3824662 polymorphism was performed using real-time polymerase chain reaction.
• The study included 104 pediatric SLE patients, 140 adult SLE patients, and 436 healthy controls matched for age and sex.

Main Results:

• No significant differences in allele or genotype frequencies of GATA3 rs3824662 were observed between SLE patients and controls.
• In pediatric SLE, the AC genotype was associated with lupus nephritis (p=0.04) and persistent proteinuria (p=0.01).
• The A allele and AC genotype were linked to higher chronicity index (p<0.05), while the C allele was associated with cellular cast and thrombocytopenia in adult SLE.

Conclusions:

• The GATA3 rs3824662 polymorphism is not associated with susceptibility to SLE in either adult or pediatric populations.
• In pediatric SLE patients, the heterozygous AC genotype may be a risk factor for lupus nephritis and a predictor for active renal disease.
• The study acknowledges a small sample size as a limitation for interpreting positive associations.